rifaximin

Shares of Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP) skyrocketted today, a day after the Gastrointestinal Drugs Advisory Committee of the FDA voted 14 to 4 in favor of the use of the company's XIFAXAN (rifaximin) 550 mg Tablets for the maintenance of remission of hepatic encephalopathy. BMO...